Introduction {#s1}
============

The Slo1 channel, also known as BK or MaxiK, distinguishes itself from other K^+^ channels by its unusually large single-channel conductance (\~10--20 times greater than most other K^+^ channels) and dual regulation by intracellular Ca^2+^ and membrane voltage ([@bib54]; [@bib63]; [@bib7]; [@bib44]; [@bib46]; [@bib24]; [@bib4]; [@bib1]; [@bib12]; [@bib62]; [@bib52]). Because both Ca^2+^ and membrane voltage gate Slo1, it serves as a hub in numerous physiological processes that couple membrane excitability to Ca^2+^ signaling events such as muscle contraction, audition, hormone secretion, and neurotransmitter release ([@bib20]; [@bib45]). Deficiencies in the Slo1 channel have been linked to a spectrum of diseases including hypertension, urinary incontinence secondary to overactive bladder (OAB), epilepsy, mental retardation, and autism ([@bib20]; [@bib45]).

Slo1 functions as a tetramer of the pore-forming α subunit, which is encoded by a single gene, *Slowpoke* (*KCNMA1*). Previously, we determined the atomic structures of aplysia Slo1(acSlo1) in the absence and presence of Ca^2+^ ([@bib37]; [@bib78]). These structures provided an explanation for the apparent paradox of an unusually high conductance and exquisite K^+^ selectivity, showed how the Ca^2+^ sensing mechanism can work, and showed how the Ca^2+^ and voltage sensors are in contact with each other, allowing for the possibility that the two sensing mechanisms could be directly coupled ([@bib37]; [@bib78]).

In mammals, Slo1 channels usually consist of α plus auxiliary subunits. The α subunits are similar to those of invertebrate Slo1 channels, but the auxiliary subunits represent a novel feature. Auxiliary subunits give rise to functional diversity and to tissue-specificity amongst the otherwise ubiquitously expressed Slo1 channel α subunit. There are two distinct families of auxiliary subunits discovered so far, termed β (2-transmembrane, 2-TM) and γ (single-TM) ([@bib27]; [@bib41]; [@bib42]; [@bib8]; [@bib10]; [@bib57]; [@bib80]; [@bib85]; [@bib89]; [@bib9]; [@bib90]; [@bib91]; [@bib95]). These auxiliary subunits diversify the function of Slo1 to the greatest extent compared to other modifications such as alternative splicing, phosphorylation etc. They dramatically modify nearly all aspects of Slo1's biophysical properties (including the activation and deactivation kinetics and Ca^2+^ sensitivity) as well as pharmacological characteristics (such as the channel's sensitivity to natural toxins) ([@bib56]; [@bib23]; [@bib17]; [@bib61]; [@bib47]; [@bib33]; [@bib11]; [@bib83]; [@bib70]; [@bib53]; [@bib9]; [@bib88]; [@bib90]; [@bib91]; [@bib79]; [@bib95]; [@bib45]). There are four members identified for each family (β1-β4 and γ1-γ4) and members within the same family modify channel function to very different extents. These auxiliary subunits generally do not exist in lower animals. Therefore, regulation of Slo1 by auxiliary subunits appears to be a key mechanism of functional tuning to fulfill different physiological roles in various tissues and cell types of higher animals.

How these single or 2-TM small transmembrane proteins physically associate with and modulate the large pore-forming α subunit's function has been studied by many scientists since the discovery of the first member - β1 in 1994 ([@bib27]; [@bib41]; [@bib42]). So far, no structure of a β or γ subunit alone or in complex with the α subunit has been determined to help us understand how these proteins work. In this study we present the structures of a mammalian (human) Slo1 channel consisting of the α subunit alone and in complex with the brain-enriched β4 subunit. In each case (presence and absence of β4 subunit) we have determined the structures of Ca^2+^-activated (open) and Ca^2+^-depleted (closed) conformations. We also interrogate the influence of structure-guided mutations of β4 using an electrophysiological assay.

Results {#s2}
=======

Structure determination of the human Slo1 channel in 4 states {#s2-1}
-------------------------------------------------------------

To obtain biochemically stable protein samples suitable for structural studies we modified the gene encoding the Slo1 α subunit by removing the C-terminal 57 amino acids (unstructured in the crystal structure of the human Slo1 cytoplasmic domain) ([@bib93]). This modification neither affected the function of the Slo1 channel α subunit alone nor the functional influence β subunits have on Slo1 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Co-expression with either the β1 or β4 subunit slowed the activation and deactivation kinetics of the truncated Slo1 channel and modified its apparent Ca^2+^sensitivity, as reported for the full length Slo1 channel ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib56]; [@bib23]; [@bib47]; [@bib33]). The truncated Slo1 channel fused with a C-terminal GFP was either expressed alone or co-expressed with the β4 subunit in HEK293S GnTI^-^ cells using the BacMam method ([@bib29]) and purified in the presence of Digitonin and a mixture of phospholipids using a GFP nanobody-affinity column followed by size-exclusion chromatography ([@bib26]). The final protein sample of Slo1 co-expressed with the β4 subunit contained both the α subunit and the β4 subunit confirmed by SDS-PAGE and mass spectrometry. Structures of human Slo1 in four distinct states were determined: Ca^2+^-free and Ca^2+^-bound α subunit alone as well as Ca^2+^-free and Ca^2+^-bound α-β4 complex at resolutions of 4.0 Å, 3.8 Å, 3.5 Å and 3.2 Å, respectively ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[4](#fig1s4){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). Details of the structure determinations are given in Materials and methods.

![Overall structure of the open human Slo1 channel in complex with the β4 subunit.\
(**A**) Determination of atomic structures of human Slo1 in four various states. (**B**) Overall structure of the human Slo1-β4 channel complex in the presence of 10 mM Ca^2+^ in stereo, viewed parallel to the membrane. The Slo1 channel and β4 subunits are shown in ribbon representation, and colored red and blue respectively. Green spheres represent the K^+^ ions in the selectivity filter.](elife-51409-fig1){#fig1}

###### Structure refinement and validation, related to [Figure 1](#fig1){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}.

  --------------------------------------------------------------------------------------------------------
                                    hsSlo1 + β4\                  hsSlo1 + β4\   hsSlo1\      hsSlo1\
                                    Open                          Closed         Open         Closed
  --------------------------------- ----------------------------- -------------- ------------ ------------
  Data acquisition                                                                            

  Microscope/Camera                 Titan Krios/Gatan K2 Summit                               

  Voltage (kV)                      300                                                       

  Defocus range (μM)                0.7 to 2.0                    0.7 to 2.0     0.8 to 2.4   0.8 to 2.4

  Pixel size (Å)                    1.04                          1.3            1.3          1.3

  Total electron dose (e^-^/Å^2^)   74                            89             89           89

  Exposure time (s)                 10                            15             15           15

  Reconstruction                                                                              

  Particle number                   117,791                       42,842         28,073       53,961

  Resolution (unmasked, Å)          3.7                           4.0            4.2          4.4

  Resolution (masked, Å)            3.2                           3.5            3.8          4.0

  RMS deviation                                                                               

  Bond length (Å)                   0.007                         0.007          0.007        0.01

  Bond angle (°)                    0.801                         0.946          0.950        0.94

  Ramachandran plot                                                                           

  Favored (%)                       95.55                         91.70          91.72        90.43

  Allowed (%)                       4.45                          8.30           8.16         9.46

  Outliers (%)                      0.00                          0.00           0.12         0.11

  MolProbity                                                                                  

  Clash score                       5.83                          6.07           8.56         5.36

  Rotamer outliers (%)              0.21                          0.30           1.56         0.63
  --------------------------------------------------------------------------------------------------------

The final reconstruction of the Ca^2+^-bound α-β4 complex is of highest quality compared to the others, with the majority of regions well resolved for model building ([Figure 1---figure supplements 2](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"}). The resolution of the density corresponding to the β4 extracellular region was worse than the TM regions ([Figure 1---figure supplements 2F](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"}). Still we were able to build an essentially complete model of β4 de novo using a subclass from focused-classification (see Materials and methods). Registration of the β4 subunit sequence was confirmed by recognizable large sidechains and the presence of four disulfide bonds as well as sugars attached to the two sequence-predicted and mass-spectrometry-confirmed N-glycosylation sites. The final model has good geometry and contains amino acids 16--54, 91--569, 577--615, 681--833 and 871--1056 of the α subunit and amino acids 7--205 of the β4 subunit ([Table 1](#table1){ref-type="table"}).

The above atomic model of the Ca^2+^-bound α-β4 complex was used as a starting model for the other three conformations, followed by multiple rounds of manual rebuilding in Coot and real-space refinement with Phenix ([@bib25]; [@bib2]). The final models all have good geometry ([Table 1](#table1){ref-type="table"}). Due to its highest resolution, the atomic model of the Ca^2+^-bound α-β4 complex is used for most of the structural description and analysis in this manuscript.

Quaternary structure of the open human Slo1 α-β4 channel complex {#s2-2}
----------------------------------------------------------------

The human Slo1 α subunit tetramer is organized similarly to acSlo1 ([Figure 1B](#fig1){ref-type="fig"}) ([@bib78]). Four of the β4 subunits bind to the human Slo1 tetramer, extending the channel extracellularly by about 40 Å when viewed from the side ([Figure 1B](#fig1){ref-type="fig"}). The complex has dimensions of approximately 150×150×150 Å. Consistent with disulfide crosslinking data in the literature, β4 subunits are located between voltage sensor domains (VSDs) and each β4 subunit contacts two neighboring VSDs simultaneously ([Figure 1B](#fig1){ref-type="fig"}) ([@bib48]; [@bib86]; [@bib49]; [@bib87]). The 120-amino acid linker between the two TMs (TM1 and TM2) of β4 forms a well-ordered structure on the extracellular side (termed 'EC domain' throughout the manuscript). Four EC domains form a 'crown' on top of the Slo1 channel ([Figure 1B](#fig1){ref-type="fig"}).

The protein sample contained high concentrations of Ca^2+^ and Mg^2+^ (10 mM each). As expected, the channel adopts an open conformation and both Ca^2+^ binding sites (the Ca-RCK1 site and the Ca-bowl site) in the gating ring and the Mg^2+^ binding site at the interface between RCK1 and the VSD are occupied, as observed in acSlo1 under the same buffer conditions ([@bib78]).

Structure of the β4 subunit {#s2-3}
---------------------------

[Figure 2A](#fig2){ref-type="fig"} shows a ribbon representation of the β4 subunit monomer in stereo. As predicted from the primary sequence, the β4 subunit contains two long transmembrane helices, TM1 and TM2 ([Figure 2A](#fig2){ref-type="fig"}). Density for the N-terminal six amino acids as well as the C-terminal five amino acids (residues 206--210) were not visible in the open Slo1-β4 complex, indicating their structural flexibility. Amino acids 7--11 form a short loop (termed 'N-loop') preceding TM1 ([Figure 2A](#fig2){ref-type="fig"}). TM1 kinks near the extracellular membrane interface and extends further into the extracellular space about four additional helical turns while TM2 extends beyond the intracellular membrane interface into the cytoplasm ([Figure 2A](#fig2){ref-type="fig"}). TM1 and TM2 within the β4 monomer form an extensive interface with mostly hydrophobic interactions ([Figure 2B](#fig2){ref-type="fig"}). The extended C-terminal part of TM2 also interacts with the N-loop through a few hydrogen bonds ([Figure 2B](#fig2){ref-type="fig"}).

![Architecture of the β4 subunit.\
(**A**) Stereo view of the β4 subunit monomer in ribbon representation with the extracellular side up. The N-terminal loop ('N-loop'), TM1, extracellular domain ('EC') and TM2 are discretely colored gray, cyan, pink and blue. The gray bars delimit the membrane boundaries. (**B**) TM1 and TM2 within one β4 subunit interact extensively with each other. TM1 and TM2 are shown as ribbons in stereo view. Residues involved in the interactions are shown in sticks and colored according to atom type. (**C**) The EC domain of β4 subunit in stereo, viewed parallel to the membrane. The protein is shown as ribbons and colored as in panel (**A**). Four disulfide bonds and 2 N-glycosylation sugar groups are shown as sticks and colored according to atom type. (**D, E**) The β4 subunit tetramer in ribbon representation viewed parallel to the membrane (**D**) or from the extracellular side (**E**). Interfaces between two neighboring EC domains are highlighted by dotted circles. (**F, G**) The interface between the EC domain of two neighboring β4 subunits viewed parallel to the membrane (**F**) or from the extracellular side (**G**). The two EC domains are colored blue and pink. Sidechains of residues at the interface are shown as sticks and colored according to atom type.](elife-51409-fig2){#fig2}

The well-ordered EC domain, which connects TM1 and TM2, contains mostly β strands (βA-βE, βH-βI), two short α helices (αF-αG) and loops in between ([Figure 2A and C](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). The structure is held together by four disulfide bonds ([Figure 2C](#fig2){ref-type="fig"}). The β4 EC domain also contains two predicted N-glycosylation sites, with one of them conserved among all the β subunits ([Figure 2C](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Glycosylation at these two predicted sites were confirmed with tandem ms/ms and extra density near both sites was observed in the final map, most likely representing the sugars. Glycosylation was shown to regulate the sensitivity of Slo1-β4 to iberiotoxin and also modify other biophysical properties of Slo1-β1 ([@bib39]; [@bib34]). In the open Slo1-β4 model, these two glycosylation sites are located at the outer periphery of the EC domain, far from the β4/β4 or α/β4 interfaces ([Figure 2C](#fig2){ref-type="fig"}). Therefore, the structure does not obviously explain the functional effects of these modifications. We note that proteins in this study were expressed using a glycosylation-deficient strain that produces smaller sugar groups. We cannot rule out the possibility that these sugars under physiological conditions might form carbohydrate-carbohydrate or carbohydrate-protein interactions not observed in the current structural model. The secondary structural elements as well as the four disulfide bonds match a recently published NMR structure of the extracellular loop of human β4 ([@bib84]). However, our Slo1-β4 complex structure exhibits a completely different tertiary structure of the EC domain than that proposed on the basis of NMR experiments. Based on a hypothetical Slo1-β4 model constructed from NMR titration and the β4 EC solution structure, N123 on β4 was suggested to be critical for regulating Slo1 gating through interactions with E264 on the turret of the α subunit upon Ca^2+^ binding ([@bib84]). The distance between sidechains of these two residues was hypothesized to shift from 10.6 Å to 5.5 Å when the channel opens, allowing them to interact. However, these two residues are more than 27 Å apart in our open Slo1-β4 complex structure and remained essentially static in the closed Slo1-β4 complex structure, making any direct interactions very unlikely.

No structural homologs of the EC domain have been reported. A search of the protein data bank using Dali revealed only proteins sharing part of the structure with the top hits being mostly nucleotide binding proteins (such as exosome complex component RRP45 and translation initiation factor 2 γ subunit), which contain some of the β strands, and certain toxins (such as pertussis toxin and subtilase cytotoxin), which contain much shorter helices and loops. The physiological importance of this EC domain must await further study (see Discussion).

The stoichiometry of α and β subunits was assumed generally to be 1:1. Evidence of sub 1:1 stoichiometry emerged from analysis of co-expression in oocytes ([@bib82]) as well as in native tissues ([@bib76]; [@bib22]; [@bib43]). It was proposed that a Slo1 channel can contain zero to four β subunits, with each β subunit incrementally influencing channel gating properties ([@bib82]). In the Slo1-β4 complex structure, β4 binds to the α subunit with 1:1 subunit stoichiometry (i.e. four β4 subunits per tetramer of α subunits) ([Figures 1B](#fig1){ref-type="fig"} and [2D--E](#fig2){ref-type="fig"}). The four β4 subunits form extensive interfaces with neighboring EC domains, encompassing a buried area of \~907 Å^2^/monomer ([Figure 2D--G](#fig2){ref-type="fig"}). The protein sample used for EM studies was produced by overexpressing β4, thus we cannot rule out the possibility that a sub 1:1 β:α complex could exist under physiological conditions. However, the structure would predict a more stable conformation upon tetramer formation because the EC domain, which interacts extensively with itself, makes only minimal contact with the α subunit ([Figures 1B](#fig1){ref-type="fig"} and [2D--G](#fig2){ref-type="fig"}).

Chemical nature of interfaces between β4 and α {#s2-4}
----------------------------------------------

Many biochemical and molecular biological studies have analyzed interactions between Slo1 and β subunits using, for example, disulfide crosslinking and TOXCAT assays ([@bib48]; [@bib86]; [@bib49]; [@bib59]; [@bib87]). TM1 was predicted to be in the vicinity of S1 and S2 on the VSD ([@bib48]; [@bib86]; [@bib49]; [@bib87]) and direct interactions between TM1 of β2 and S1 of the VSD were found using the TOXCAT assay ([@bib59]). In our Slo1-β4 structure, β4 associates with the α subunit almost exclusively through the two TM helices ([Figure 3A](#fig3){ref-type="fig"}). The TM1 segment near the outer leaflet of the membrane contacts the transmembrane domain (TMD) from one α subunit ('α1') through hydrophobic interactions with sidechains from S1 and the pore helix (PH), while at the same time interacting with sidechains from S6 and the turret of a contiguous α subunit ('α2') ([Figure 3A--B](#fig3){ref-type="fig"}). Notably, lipid molecules also contribute to these interfaces ([Figure 3A--B](#fig3){ref-type="fig"}). The TM1 segment near the inner leaflet acyl chain region mostly contacts S3 of α2 and several ordered lipid molecules through hydrophobic interactions ([Figure 3C](#fig3){ref-type="fig"}). The bottom of TM1, near the intracellular membrane interface, makes contacts with multiple regions of the α subunit including the S2-S3 linker and S0 from α2, the S6-RCK1 linker from α1 and phospholipid headgroups through hydrogen bonds ([Figure 3C](#fig3){ref-type="fig"}). With the same TOXCAT assay, no direct association with the α subunit was detected for TM2, the EC domain, or the C-terminus of β and it was thus suggested that there are no strong interactions between TM2 and S0 despite the nearness predicted from the disulfide crosslinking experiments ([@bib48]; [@bib86]; [@bib49]; [@bib59]; [@bib87]). Our structure shows that the TM2 outer leaflet segment only interacts with α2. Furthermore, this interface is purely mediated by lipid molecules forming a hydrophobic core with TM2 sidechains ([Figure 3A--B](#fig3){ref-type="fig"}). The TM2 inner leaflet segment forms an extensive protein:protein interface with S0 and S3 from α2 ([Figure 3A and C](#fig3){ref-type="fig"}). The residues of β4 directly involved in the α/β association turn out to be fairly conserved among β1-β4 ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). Therefore, it would seem likely that β1-β4 subunits all bind to Slo1 in a similar fashion. Furthermore, Slo1 residues involved in these specific interactions appear to be conserved between Slo1 and Slo3, which would explain why all members of the β subunit family also physically associate with Slo3 ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}) ([@bib92]). We emphasize the general observation that lipid molecules make significant contributions to the α/β interfaces at both the inner and outer membrane leaflets, suggesting they are an integral part of the Slo1 α-β4 channel complex ([Figure 3](#fig3){ref-type="fig"}).

![Detailed interactions between Slo1 and β4.\
(**A**) Extensive interactions between TM1, TM2 of β4 subunit and transmembrane domains of two contiguous Slo1 subunits (α1 and α2) in stereo. β4 and Slo1 are shown as ribbons and colored blue and red, respectively. Sidechains as well as lipids at the interfaces are shown as sticks and colored according to atom type. (**B**) β4 and Slo1 interface near the outer leaflet of the membrane in stereo, viewed from the extracellular side. Proteins and lipids are represented and colored as in panel (**A**). Green spheres represent the K^+^ ions in the selectivity filter. (**C**) β4 and Slo1 interface near the inner leaflet of the membrane in stereo, viewed from the intracellular side. Proteins and lipids are represented and colored as in panel (**A**).](elife-51409-fig3){#fig3}

In the open α-β4 model, the N-loop preceding TM1 is located adjacent to the S6-RCK1 linker and the αC helix of the RCK1 N-lobe, making short and long-range interactions between these regions likely. T11 of β4 is less than 5 Å away from D173 in the S2-S3 loop of the α subunit; the E12 sidechain of β4 is about 5.5 Å away from R329 in the S6-RCK1 linker and is also in the vicinity of W176 on S3 and H409 on the αC helix.

Wang et. al. suggested that the EC domain of β1 might interact with the extracellular side of the Slo1 VSD, as mutations in that region caused appreciable changes in Slo1 gating ([@bib32]). The Slo1-β4 complex structure shows essentially no direct association between the β4 EC domain and the α subunit. The functional effects they observed from the mutations could be due to indirect effects.

Influence of β4 N-terminus on Slo1 gating {#s2-5}
-----------------------------------------

β1 and β4 subunits slow the kinetics of Slo1 activation and deactivation in response to voltage steps ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [Figure 4A](#fig4){ref-type="fig"}). We sought to identify regions of β4 that mediate these rate changes. Guided by the structure, we divided β4 into 10 regions depicted in [Figure 4B](#fig4){ref-type="fig"} and described in detail in Materials and methods. Mutants were made by replacing one or more of these 10 regions of β4 mainly with the equivalent sequence from β1 ([Figure 4B](#fig4){ref-type="fig"} and [Table 2](#table2){ref-type="table"}). The β1 sequence -- instead of alanine or other substitutions -- was used, reasoning this would more likely achieve expression and assembly of a functional complex. Co-expression was carried out in Xenopus oocytes and currents were recorded under two-electrode voltage clamp (TEVC), as shown ([Figure 4](#fig4){ref-type="fig"}). Activation and deactivation kinetics were quantified by fitting a single exponential function to the current time course ([Figure 4C](#fig4){ref-type="fig"}).

![Influence of β4 N-terminus on Slo1 gating.\
(**A**) Voltage-dependent channel activation of the human Slo1 channel alone and co-expressed with the β1 or β4 subunit. Representative current traces recorded using two-electrode voltage clamp (TEVC) are shown. Recording buffer: HEPES 5 mM, KCl 98 mM, CaCl~2 ~0.3 mM, and MgCl~2 ~1 mM. Voltage protocol: holding potential 0 mV, step from −80 to 120 mV in 10 mV incremental steps, step back to 40 mV. A superposition of one single sweep (stepping to 100 mV) from the left three recordings is shown on the right. (**B**) A schematic drawing of the β4 subunit showing the 10 regions divided based on the atomic structure. (**C**) Quantification of channel activation and deactivation kinetics by fitting with a single exponential function (see Materials and methods). (**D**) Comparison of three pairs of mutants demonstrated that the nature of N-tail is correlated with the activation kinetics: the presence of β4 N-tail (left column) results in slower activation kinetics than β1 N-tail (right column). Schematic drawing of each corresponding mutant is shown next to the representative current traces. Voltage protocols are the same as in panel (**A**).](elife-51409-fig4){#fig4}

###### List of the β4 mutants for TEVC studies, related to [Figure 4](#fig4){ref-type="fig"}.

  --------------------------------------------------------------------------------------------------------------------------------------------------
  ShortName   β4 sequence                                  β1 sequence     \   ShortName   β4 sequence                               β1 sequence
  ----------- -------------------------------------------- --------------- --- ----------- ----------------------------------------- ---------------
  Slo1        N/A                                          N/A                 m27         1-10,20-190,206-210                       10-18,178-191

  β1          N/A                                          1-191               m28         11-193                                    1-9,181-191

  β4          1-210                                        N/A                 m29         11-198                                    1-9,181-186

  m2          7-210                                        N/A                 m30         49-210                                    1-47

  m3          1-205                                        N/A                 m31         1-163                                     151-191

  m4          10-210                                       N/A                 m32         1-10,49-210                               10-47

  m5          14-210                                       1-12                m33         1-163,206-210                             151-191

  m6          1-34,40-210                                  34-38               m34         1-10,49-163                               10-47,151-191

  m7          1-190,197-210                                178-183             m35         1-28,49-210                               28-47

  m8          1-10,14-210                                  10-12               m36         1-163,181-210                             151-167

  m9          E9A                                          N/A                 m37         1-19,30-210                               19-28

  m10         1-18,20-210 (R19C)                           18                  m38         1-180,191-210                             168-177

  m11         R19L                                         N/A                 m39         1-10,30-210                               10-28

  m12         E14A                                         N/A                 m40         1-180,206-210                             168-191

  m13         1-42,44-210 (A43Y)                           42                  m41         1-10,20-210                               10-18

  m14         1-164,168-210                                152-154             m42         1-190,206-210                             178-191

  m16         7-205                                        N/A                 m43         11-210                                    1-9

  m17         1-42,44-164,168-210                          42,152-154          m44         replace β4EC (49-166) with \"GGSGGGSG\"   N/A

  m18         1-11,13-14,16-18,20-210 (E12R, D15T, R19C)   11,14,18            m45         replace β1EC (41-153) with \"GGSGGGSG\"   N/A

  m19         1-48,164-210                                 48-150              m46         replace β1EC (48-153) with \"GGSGGGSG\"   N/A

  m20         1-45,167-210                                 45-153              m47         1-47,151-210                              49-163

  m21         49-163                                       1-47,151-191        m48         1-44,154-210                              46-166

  m22         1-10,49-163,206-210                          10-47,151-191       m49         1-6,49-210                                6-47

  m23         1-10,49-163,196-210                          10-47,151-182       m50         1-6,30-210                                6-28

  m24         1-28,49-163,181-210                          28-47,151-167       m51         1-2,30-210                                2-28

  m25         1-19,30-180,191-210                          19-28,168-177       m52         1-6,20-210                                6-18

  m26         1-10,30-180,206-210                          10-28,168-191       m53         1-2,20-210                                2-18
  --------------------------------------------------------------------------------------------------------------------------------------------------

[Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"} shows the plot of activation time constants (τ_on) of wild-type (wt) and all mutants in an ascending order from left to right. Based on their difference from the β4 or β1 wt values, these mutants are subdivided into four categories ranging from τ_on less than one half that of β4 wt (i.e. faster rates) to greater than two times β4 wt (i.e. slower rates). Deactivation time constants (τ_off) were plotted in a similar fashion ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Mutants with faster activation rates were distributed throughout the β4 structure, while those with significantly slower activation rates were distributed with some bias towards the inner leaflet region of TM1, the N-loop, and the N-tail ([Figure 4---figure supplement 1A and C](#fig4s1){ref-type="fig"}, [Table 2](#table2){ref-type="table"}). While mutations affecting τ_on were not strongly correlated with effects on τ_off, those causing the greatest slowing of deactivation also involved the N-terminus of TM1, the N-loop and N-tail ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"} and [Table 2](#table2){ref-type="table"}).

Although not observed in the cryo-EM structure, the N-tail plays a definitive role in determining activation kinetics. Specifically, mutants containing the N-tail of β4 activate more slowly than those with the N-tail of β1. This effect is demonstrated in [Figure 4D](#fig4){ref-type="fig"}, which shows the influence of the β4 versus the β1 N-tail independent of mutations elsewhere in the body of the β subunit. The importance of the β subunit N-terminus to gating has already been proposed ([@bib16]). We also observe that removal of the N-tail results in a modest increase in the rate of activation ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Table 2](#table2){ref-type="table"}). In the open structure of the Slo1 α-β4 complex, the N-loop of β4 is located next to the S6-RCK1 linker of α. It would seem likely that the close proximity of this N-terminal region, including the N-tail of the β4 subunit, to an important gating region of the α subunit, the S6-RCK1 linker, somehow underlies the effects on activation that we observe.

Ca^2+^-induced Pore Opening in the Context of the β4 Subunit {#s2-6}
------------------------------------------------------------

Ca^2+^ binding to two unique Ca^2+^ binding sites per α subunit produces protein conformational changes that splay the S6 (inner) helices, causing a wide pathway for ion diffusion to open between the cytoplasm and the transmembrane pore ([Figure 5A](#fig5){ref-type="fig"}). The Ca^2+^ binding sites are located within the cytoplasmic 'gating ring', which is centered on the four-fold channel axis just beneath the transmembrane pore ([Figures 1B](#fig1){ref-type="fig"} and [5B](#fig5){ref-type="fig"}). When Ca^2+^ binds, a domain of the gating ring closest to the membrane, called the RCK1 N-lobe, expands away from the channel's central axis; expansion of all four RCK1 N-lobes, one from each subunit, produces a radial expansion, as shown ([Figure 5B](#fig5){ref-type="fig"}). Since the RCK1 N-lobes are connected directly to the S6 helices via the S6-RCK1 linkers, their expansion produces pore opening. Structural details of the Ca^2+^ binding site reorganization upon Ca^2+^ binding, RCK1 N-lobe expansion and pore opening observed in human Slo1 are essentially the same as those observed previously in acSlo1 ([@bib37]; [@bib78]). Thus, the intricacies of Ca^2+^-mediated pore opening are conserved among Slo1 channels from invertebrates to mammals.

![Ca^2+^gating mechanism of human Slo1 in the absence and presence of β4 subunit.\
(**A**) Ca^2+^-induced conformational changes in the pore domain of human Slo1-β4 channel complex. Superposition of the pore domain in the absence (red Cα trace) and presence (blue Cα trace) of Ca^2+^ is shown in stereo. The gating hinge residue G310 on inner helix is labeled. (**B**) Ca^2+^-induced conformational changes in the gating ring of human Slo1-β4 channel complex. Superposition of the gating ring (aligning the RCK2 domain) in the absence (red) and presence (blue) of Ca^2+^ is shown in stereo. The spheres indicate the position of Cα atoms of Gly334 at the beginning of RCK1 domain. Distances between the Cα atoms of Gly334 on opposing RCK1 subunits are labeled. (**C**) Ca^2+^ produced essentially no conformational changes in the β4 tetramer. Superposition of the β4 tetramer in the absence (red) and presence (blue) of Ca^2+^ is shown. (**D, E**) Ca^2+^ produced minimal conformational changes in the Slo1-β4 interfaces near the membrane outer leaflet, including the positions of lipid molecules, viewed parallel to membrane (**D**) or from the extracellular side (**E**). Superposition of the Slo1-β4 channel complex in the absence (red) and presence (blue) of Ca^2+^ is shown, aligning the transmembrane domain. For clarity, only one β4 subunit (as ribbons) and the two interacting Slo1 subunits (α1 and α2) (as cylinders) are shown. Lipids at the Slo1 and β4 TM1 outer leaflet interface are shown as sticks. K^+^ ions in the selectivity filter are show as marine spheres (**E**). (**F**) Ca^2+^-induced conformational changes in the Slo1-β4 interfaces near the membrane inner leaflet. Superposition of the Slo1-β4 channel complex in the absence (red) and presence (blue) of Ca^2+^ is shown in stereo, viewed parallel to the membrane, aligning the transmembrane domain. Sidechains of the β4 TM1 facing the S6-RCK1 linker as well as the three positively charged residues on S6-RCK1 linker ('RKK') are shown as sticks. Lipids at the Slo1 and β4 TM1 inner leaflet interface in the Ca^2+^-bound state are also shown as sticks. (**G**) Superposition of the Slo1-β4 channel complex in the absence (red) and presence (blue) of Ca^2+^ viewed from the intracellular side, aligning the transmembrane domain. Color and representation schemes are the same as in panel (**F**). Sidechains of the β4 TM1 facing the S6-RCK1 linker as well as the three positively charged residues on S6-RCK1 linker ('RKK') are shown as sticks. (**H**) The same superposition as in panel (**G**) with lipids at the Slo1 and β4 TM1 inner leaflet interface in the Ca^2+^-bound state (blue) and Ca^2+^-free state (red) shown as sticks.](elife-51409-fig5){#fig5}

The Ca^2+^-bound structures of the human Slo1 α subunit determined in the absence and presence of the β4 subunit are essentially identical to each other (RMSD 2.0 Å) ([Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Likewise, the two Ca^2+^-free structures of the α subunit (± β4 subunit) are also the same within the accuracy of our measurements (RMSD 1.1 Å) ([Figure 5---figure supplement 1B](#fig5s1){ref-type="fig"}). Contrasting the large Ca^2+^-mediated conformational changes that occur within the α subunit pore ([Figure 5A](#fig5){ref-type="fig"}) and gating ring ([Figure 5B](#fig5){ref-type="fig"}) with the absence of conformational change in the β4 subunit ([Figure 5C](#fig5){ref-type="fig"}) gives the impression that the β4 subunits encage the α subunit channel without interfering with its Ca^2+^-mediated gating conformational changes. Within the outer leaflet of the membrane even lipid molecules that mediate interactions between the α and β subunits remain unperturbed ([Figure 5D and E](#fig5){ref-type="fig"}). Within the inner leaflet of the membrane, where large gating conformational changes in the α subunit occur ([Figure 5A and F--H](#fig5){ref-type="fig"}), interfaces between α and β subunits -- especially surrounding the more centrally located TM1 of the β subunit -- undergo change. This N-terminal segment of TM1 corresponds to the region where mutations had the largest influence on gating kinetics ([Figure 5F--H](#fig5){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

In functional studies, β subunits alter the apparent Ca^2+^ sensitivity of gating. But the sensitivity changes are not thought to reflect changes in intrinsic Ca^2+^ affinity for the binding sites, but instead are proposed to reflect indirect effects that β subunits have on α subunit conformational changes that are coupled to Ca^2+^ binding ([@bib21]; [@bib60]; [@bib6]; [@bib70]; [@bib19]). The structures support this proposal because the Ca^2+^ binding sites are unaltered by the presence of β subunits ([Figure 5---figure supplement 1C--F](#fig5s1){ref-type="fig"}). This study only determined structures at very low and very high Ca^2+^ concentrations. Had we determined structures at intermediate Ca^2+^ concentrations we suspect that we would observe the same closed and open conformations with a distribution accounting for their relative probabilities weighted according to the Ca^2+^ concentration ([@bib38]). We expect that the 'weighting function' would be altered by the presence of β subunits. The structural data support the idea that β subunits stabilize or destabilize conformational states of the α subunits rather than creating new states. The RCK1 N-lobe and S6-RCK1 linker region of the α subunit is one likely region where β subunits exert their effects. We also must point out that the structures determined in this study, corresponding to a cycle relating β subunits to Ca^2+^ binding ([Figure 1A](#fig1){ref-type="fig"}), are silent on direct effects that the β subunits could have on different conformations of the voltage sensors. It is very possible that yet unknown structural changes brought about by a transmembrane electric field could alter interactions between β subunits and the voltage sensors of the α subunits. Direct stabilization of different conformations of voltage sensors by β subunits remains a distinct mechanistic possibility ([@bib6]; [@bib70]; [@bib19]).

Structural basis for modification of Slo1 toxin sensitivity by β subunits {#s2-7}
-------------------------------------------------------------------------

Certain protein toxins from scorpion venoms inhibit K^+^ channels by plugging their extracellular pore entryway ([@bib3]; [@bib51]). Our understanding of these toxins' mechanism of action as pore blockers comes mainly from studies of charybdotoxin (CTX) and Iberiotoxin (IbTX) inhibition of Slo1 channels ([@bib14]; [@bib28]; [@bib58]). The large conductance of Slo1 has enabled the measurement of toxin association and dissociation events in single channel recordings ([@bib51]). About 30 years ago a Slo1 with altered toxin binding properties was discovered ([@bib68]). The altered properties were later attributed to the presence of β4 subunits ([@bib8]; [@bib10]; [@bib57]; [@bib85]; [@bib47]). We now know that different β subunits confer unique pharmacological profiles to the Slo1 channel ([@bib8]; [@bib10]; [@bib47]). Studies with mutant β subunits showed that toxins are most sensitive to the composition of the EC domain ([@bib57]).

The α-β4 structure provides a simple explanation for the general observation that β subunits slow the rates of association and dissociation of toxins with the channel: the EC domain crown limits access to the toxin binding site. Using the crystal structure of CTX bound to the Kv1.2-Kv2.1 paddle chimera channel to model CTX binding to Slo1, we conclude that there is adequate space for toxin binding within the cage beneath the crown, but that CTX has restricted access across the central opening to reach its binding site ([Figure 6A--C](#fig6){ref-type="fig"} and [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}) ([@bib5]). The toxin is elongated along one axis and likely has to orient with its long axis parallel to the 4-fold axis to pass through the opening on the top of the crown. Optimal orientation will still require amino acid sidechain adjustments on both the toxin and β subunits to permit passage. Restricted access rationalizes a reduced association rate (compared to a Slo1 channel without β subunits) if the probability of successful encounter is reduced ([@bib74]). Analogously, a reduced dissociation rate would reflect a reduced probability of toxin exit. If the toxin releases from its binding site and tumbles within the cage beneath the crown, rebinding many times before finally exiting, the resultant effect would be purely kinetic (the assumption here being that release and rebinding without dissociation from the cage would be too rapid to resolve as dissociation events in channel recordings). If, on the other hand, toxin is stabilized on its binding site by the β subunit, then equilibrium effects (i.e. effects on affinity) would also be expected. Data suggest that both kinetic (i.e. rate changes that could be modeled through a barrier height) and equilibrium effects (i.e. affinity changes that could be modeled through the depth of a toxin binding well) occur ([@bib8]; [@bib10]; [@bib57]; [@bib47]).

![Structural basis for modification of Slo1 toxin sensitivity by β subunits.\
(**A**) CTX docked onto the Slo1 channel based on the crystal structure of the CTX-Kv1.2--2.1 paddle chimera (PDB 4JTA). Only the transmembrane domain of Slo1 is shown (gray surface) and CTX is shown as pink ribbons. Dimensions of CTX in the plane parallel to membrane are indicated. (**B**) Central conduction pore of the open Slo1-β4 channel complex generated with Hole ([@bib75]). For clarity, only two opposing subunits of Slo1 and β4 are shown (blue and red Cα traces). Pore radius: red,\<1.15 Å; green, 1.15 to 2.30 Å; orange,\>2.30 Å. (**C**) Diameter of the central pore. The van der Waals radius is plotted against the distance along the pore axis. (**D**) The EC domain tetramer of β4 provides potential new toxin binding sites. The EC tetramer is shown as blue ribbons. CTX is shown as pink sticks and ribbons. Potential new CTX binding sites on the EC domain and the corresponding interacting residues on CTX are shown as sticks and colored according to atom type. (**E**) Electrostatic surface potential of CTX viewed from the extracellular side ('Top') or the opposite side ('Bottom'), calculated with APBS. (**F**) Negatively charged inner surface of the central pore formed by the EC tetramer of β4 subunits, calculated with APBS. (**G, H**) Two rings of negatively charged residues E64 and E67 on the EC domain of β4, facing the central pore axis, viewed parallel to the membrane (**G**) or from the extracellular side (**H**). EC domains are shown as blue ribbons. Sidechains of E64 and E67 are shown as sticks and colored according to atom type.](elife-51409-fig6){#fig6}

A number of prior experiments and conclusions are consistent with the α-β4 structure. In 1994 Garcia and colleagues demonstrated that K69 on β1 (corresponding to R77 on β4) can be cross-linked to CTX ([@bib40]). R77 is located inside the cage formed by the EC domain crown, facing the backside of CTX (i.e. the side opposite the pore's selectivity filter) ([Figure 6D](#fig6){ref-type="fig"}). Scorpion toxins generally are electropositive on their surface: CTX and IbTX contain a total of 8 and 7 positively charged residues, respectively ([Figure 6E](#fig6){ref-type="fig"} and [Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Garcia et. al. speculated that certain negatively charged residues within the large extracellular loop of the β subunit attract CTX to its binding site on the α subunit ([@bib35]). In line with this hypothesis, the inner surface of the cage formed by the EC domain crown is electronegative due to the presence of two rings of negatively charged residues -- E64 and E67 ([Figure 6F--H](#fig6){ref-type="fig"}). These positions are almost strictly conserved as negatively charged residues (E or D) in β1 to β4 ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), which would create electrostatic interactions between the toxin and the β subunit. Mutations made on the back side of CTX have little effect on affinity for Slo1 without β subunits ([@bib64]). The structural model predicts that some of the same CTX mutations are likely to have an effect in the presence of β subunits ([Figure 6D](#fig6){ref-type="fig"}).

Discussion {#s3}
==========

The ion channel composed of the α subunit of Slo1 forms a functional Ca^2+^- and voltage-gated K^+^ channel. In different cells within an organism the functional properties of Slo1 are not all the same: variations in the kinetics of channel opening and closing and in the apparent Ca^2+^ sensitivity are observed. These variations exist because the functional properties of Slo1 channels are 'tuned' through RNA splicing, posttranslational modifications, and assembly of the Slo1 α subunit with auxiliary β or γ subunits. In this study we for the first time visualize the assembly of the Slo1 α subunit with an auxiliary subunit, the β4 subunit. The structure offers a mechanistic picture explaining certain functional properties, such as the influence of β subunits on toxin interactions with Slo1. The structure also implies that the N-terminus of the β subunit TM1 and the segment of β4 preceding TM1 influence channel gating through interactions with the gating ring RCK1 N-lobe and the S6-RCK1 linker. As is often the case, because functional properties of a protein can be sensitive to atomic displacements smaller than the resolution of a structure, many functional effects of β subunits are not easily explained by the structure. For the unexplained properties, the structure still serves as an essential starting point for future understanding.

The Slo1 β subunits are one example of relatively small (i.e. TM segments not much larger than a few lipid molecules) membrane proteins that regulate the function of ion channels. Slo1 also has γ subunits, the KCNQ (Kv7) voltage-dependent K^+^ channels co-assemble with single membrane-spanning KCNE subunits, Kv4 co-assembles with dipeptidyl aminopeptidase-like (DPPL) proteins and voltage-dependent Na^+^ (Nav) channels are also associated with auxiliary subunits ([@bib66]; [@bib13]; [@bib95]). These small transmembrane proteins are generally multifunctional, affecting various aspects of the larger target protein including trafficking/surface expression, biophysical properties, pharmacological profiles, and assembly into functional complexes ([@bib66]; [@bib97]; [@bib13]). DPPL for Kv4 has been implicated in binding to components of the extracellular matrix through its extracellular domain ([@bib66]), and the Nav β subunit extracellular domain plays a crucial role in cell adhesion and migration ([@bib13]). Whether the structured crown of Slo1 β subunits (sequence similarity virtually guarantees a similar extracellular structure in β1-β3 as well) interacts with extracellular matrix proteins to localize Slo1 channels to specific regions of a cell, perhaps regions of contact with other cells, is still unknown, but seems like a good possibility.

Another idea we have when looking at the α-β4 Slo1 structure is inspired by the location of the β subunit TM helices. When they encircle the α subunit, they must displace lipid molecules. As shown in the structures, certain lipid molecules are bound at the α/β subunit interfaces, but the presence of β subunits necessitates the displacement of some lipids. We know that the function of many ion channels is very sensitive to the membrane lipid composition ([@bib36]; [@bib81]; [@bib72]; [@bib73]; [@bib18]). Thus, we consider it perhaps useful to view these small transmembrane spanning proteins as membrane components that, like lipids, by altering the chemical and physical properties of the surrounding membrane, alter the function of the ion channel.

Materials and methods {#s4}
=====================

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                    Designation                                             Source or reference                                                                   Identifiers                                               Additional\                                                                                
  (species) or resource                                                                                                                                                                                                                                    information                                                                                
  ------------------------------------------------ ------------------------------------------------------- ------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------ --
  Gene (*Homo sapiens*)                            hsSlo1 (human_KCNMA1)                                   synthetic                                                                             accession: Q12791.2\                                      synthesized at GeneWiz                                                                     
                                                                                                                                                                                                 GI: 46396283                                                                                                                                         

  gene (*Homo sapiens*)                            hsbeta4 (human_KCNMB4)                                  synthetic                                                                             accession: NP_055320.4\                                   synthesized at GeneWiz                                                                     
                                                                                                                                                                                                 GI: 26051275                                                                                                                                         

  gene (*Homo sapiens*)                            hsbeta1(human_KCNMB1)                                   synthetic                                                                             accession: Q16558.5\                                      synthesized at GeneWiz                                                                     
                                                                                                                                                                                                 GI: 292495100                                                                                                                                        

  Recombinant DNA reagent                          pEG BacMam                                              DOI: [10.1038/nprot.2014.173](https://doi.org/10.1038/nprot.2014.173)                                                                                                                                                                      

  Recombinant DNA reagent                          pGEM                                                    <https://www.addgene.org/vector-database/2835/>                                                                                                                                                                                            

  Cell line (*Homo sapiens*)                       HEK293S GnTI^-^                                         ATCC                                                                                  CRL-3022                                                  cells purchased from ATCC and we have now confirmed there is no mycoplasma contamination   

  Cell line (*Homo sapiens*)                       HEK293T                                                 ATCC                                                                                  CRL-3216                                                  cells purchased from ATCC and we have now confirmed there is no mycoplasma contamination   

  Cell line (*Spodoptera frugiperda*)              Sf9                                                     ATCC                                                                                  CRL-1711                                                  cells purchased from ATCC and we have now confirmed there is no mycoplasma contamination   

  Strain, strain background (*Escherichia coli*)   DH10Bac                                                 ThermoFisher                                                                          10361012                                                  MAX Efficiency DH10Bac Competent Cells                                                     

  Biological sample (*Xenopus laevi*)              oocyte                                                  *Xenopus laevi*                                                                                                                                                                                                                            

  Chemical compound, drug                          Freestyle 293 medium                                    Gibco                                                                                 12338018                                                                                                                                             

  Chemical compound, drug                          sf-900 II SFM medium                                    Gibco                                                                                 10902088                                                                                                                                             

  Chemical compound, drug                          2,2-didecylpropane-1,3-bis-β-D-maltopyranoside (LMNG)   Anatrace                                                                              NG310                                                                                                                                                

  Chemical compound, drug                          Cholesteryl hemisuccinate (CHS)                         Anatrace                                                                              CH210                                                                                                                                                

  Chemical compound, drug                          Digitonin                                               Sigma-Aldrich                                                                         D141                                                                                                                                                 

  Chemical compound, drug                          Cellfectin II                                           Invitrogen                                                                            10362100                                                                                                                                             

  Chemical compound, drug                          FuGENE HD transfection reagent                          Promega                                                                               E2312                                                                                                                                                

  Chemical compound, drug                          Collegenase type II                                     Gibco                                                                                 17107--0125                                                                                                                                          

  Chemical compound, drug                          Gentamicin sulphate                                     Sigma-Aldrich                                                                         A0752                                                                                                                                                

  Commercial assay or kit                          CNBr-activated sepharose beads                          GE Healthcare                                                                         17043001                                                                                                                                             

  Commercial\                                      Superose 6, 10/300 GL                                   GE Healthcare                                                                         17517201                                                                                                                                             
  assay or kit                                                                                                                                                                                                                                                                                                                                        

  Commercial assay or kit                          mMESSAGE mMACHINE T7 Transcription Kit                  ThermoFisher                                                                          AM1344                                                                                                                                               

  Commercial assay or kit                          AmpliCap-MaxT7 high yield message maker kit             CELLSCRIPT                                                                            C-ACM04037                                                                                                                                           

  Commercial assay or kit                          R1.2/1.3 400 mesh Au holey carbon grids                 Quantifoil                                                                            1210627                                                                                                                                              

  Software, algorithm                              SerialEM                                                DOI: [10.1016/j.jsb.2005.07.007](https://doi.org/10.1016/j.jsb.2005.07.007)           <http://bio3d.colorado.edu/SerialEM>                                                                                                                 

  Software, algorithm                              MotionCor2                                              DOI: [10.1038/nmeth.4193](https://doi.org/10.1038/nmeth.4193)                         <https://msg.ucsf.edu/software>                                                                                                                      

  Software, algorithm                              Gctf                                                    DOI: [10.1016/j.jsb.2015.11.003](https://doi.org/10.1016/j.jsb.2015.11.003)           <https://www.mrc-lmb.cam.ac.uk/kzhang/>                                                                                                              

  Software, algorithm                              Gautomatch                                              other                                                                                 <https://www.mrc-lmb.cam.ac.uk/kzhang/>                                                                                                              

  Software, algorithm                              cryoSPARC                                               DOI: [10.1038/nmeth.4169](https://doi.org/10.1038/nmeth.4169)                         <http://www.cryosparc.com>                                                                                                                           

  Software, algorithm                              RELION-3                                                DOI: [10.7554/eLife.18722](https://doi.org/10.7554/eLife.18722)                       <http://www2.mrc-lmb.cam.ac.uk/relion>                                                                                                               

  Software, algorithm                              FrealignX                                               DOI: [10.1016/j.jsb.2013.07.005](https://doi.org/10.1016/j.jsb.2013.07.005)           <http://grigoriefflab.janelia.org/frealign>                                                                                                          

  Software, algorithm                              COOT                                                    DOI: [10.1107/S0907444910007493](https://doi.org/10.1107/S0907444910007493)           <https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>                                                                                              

  Software, algorithm                              PHENIX                                                  DOI: [10.1107/S2059798318006551](https://doi.org/10.1107/S2059798318006551)           <https://www.phenix-online.org>                                                                                                                      

  Software, algorithm                              UCSF Chimera                                            DOI: [10.1002/jcc.20084](https://doi.org/10.1002/jcc.20084)                           <https://www.cgl.ucsf.edu/chimera>                                                                                                                   

  Software, algorithm                              Pymol                                                   PyMOL Molecular Graphics System, Schrödinger, LLC                                     <http://www.pymol.org>                                                                                                                               

  Software,\                                       HOLE                                                    DOI: [10.1016/s0263-7855(97)00009-x](https://doi.org/10.1016/s0263-7855(97)00009-x)   <http://www.holeprogram.org>                                                                                                                         
  algorithm                                                                                                                                                                                                                                                                                                                                           

  Software, algorithm                              pClamp                                                  Axon Instruments, Inc                                                                                                                                                                                                                      
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cloning, Expression and Purification {#s4-1}
------------------------------------

HsloM3 (GI: 507922, here referred to as human Slo1 or hsSlo1) was generously provided by Ligia Toro in a pcDNA3 vector and served as the template for subcloning. To improve the biochemical stability of hsSlo1, we excluded the very C-terminal 57 residues at the level of molecular biology. Specifically, a gene fragment encoding residues 1--1056 of hsSlo1 was subcloned into a modified pEG BacMam vector ([@bib29]). The resulting protein has green fluorescent protein (GFP) and a 1D4 antibody recognition sequence (TETSQVAPA) on the C-terminus, separated by a PreScission protease cleavage site (SNSLEVLFQ/GP). This truncated construct, denoted hsSlo1~EM~, was used in all the experiments of this manuscript.

Synthetic gene fragments (Genewiz) encoding full length human β4 (GI: 26051275, residues 1--210) and β1 (GI: 4758626, residues 1--191) subunit of Slo1 were subcloned into a similarly modified pEG BacMam vector with mCherry and a deca-histidine affinity tag (mCherry-His10) replacing the GFP-1D4 fragment.

HsSlo1 was either expressed alone or co-expressed with the β4 subunit in HEK293S GnTI^-^ cells using the BacMam method ([@bib29]). Briefly, bacmid carrying hsSlo1~EM~ or β4 subunit was generated by transforming *E. coli* DH10Bac cells with the corresponding pEG BacMam construct according to the manufacturer's instructions (Bac-to-Bac; Invitrogen). Baculoviruses were produced by transfecting *Spodoptera frugiperda* Sf9 cells with the bacmid using Cellfectin II (Invitrogen). Baculoviruses, after two rounds of amplification, were used for cell transduction. Suspension cultures of HEK293S GnTI^-^ cells were grown at 37°C to a density of \~3×10^6^ cells/ml. For expression of hsSlo1 alone, cell culture was infected with 15% (v:v) of hsSlo1~EM~ baculovirus. For co-expression of hsSlo1 and β4 subunit, cell culture was infected with 5% (v:v) hsSlo1~EM~ plus 15% (v:v) of β4 baculoviruses to initiate the transduction. After 20 hr, 10 mM sodium butyrate was supplemented and the temperature was shifted to 30°C. Cells were harvested \~40 hr after the temperature switch.

For the Ca^2+^-bound hsSlo1 protein sample, cells were gently disrupted by stirring in a hypotonic solution containing 10 mM Tris-HCl pH 8.0, 3 mM dithiothreitol (DTT), 1 mM EDTA supplemented with protease inhibitors including 0.1 μg/ml pepstatin A, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 0.1 mg/ml soy trypsin inhibitor, 1 mM benzamidine, 0.1 mg/ml 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride (AEBSF) and 1 mM phenylmethysulfonyl fluoride (PMSF). Cell lysate was then centrifuged for 30 min at 30,000 g and pellet was homogenized in a buffer containing 20 mM Tris-HCl pH 8.0, 320 mM KCl, 10 mM CaCl~2~, 10 mM MgCl~2~ supplemented with protease inhibitors including 0.1 μg/ml pepstatin A, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 0.1 mg/ml soy trypsin inhibitor, 1 mM benzamidine, 0.1 mg/ml AEBSF and 0.2 mM PMSF. The lysate was extracted with 10 mM lauryl maltose neopentyl glycol (LMNG) and 2 mM cholesteryl hemisuccinate (CHS) for an hour with stirring and then centrifuged for 40 min at 30,000 g. Supernatant was added to GFP nanobody-conjugated affinity resin (CNBr-activated Sepharose 4B resin from GE Healthcare) pre-equilibrated with wash buffer (20 mM Tris-HCl pH 8.0, 450 mM KCl, 10 mM CaCl~2~, 10 mM MgCl~2~, 0.005% digitonin (Sigma), 0.1 mg/ml 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE): 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC): 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (POPA) 5:5:1 (w:w:w), 0.1 μg/ml pepstatin A, 1 μg/ml aprotinin and 0.1 mg/ml soy trypsin inhibitor) ([@bib26]). The suspension was mixed by nutating for \~2 hr. Beads were first washed with 10 column volumes of wash buffer in batch mode and then collected on a column by gravity, washed with another 20 column volumes of wash buffer. The protein was then digested on resin with PreScission protease (\~20:1 w:w ratio) overnight with gentle rocking. Flow-through was then collected, concentrated and further purified on a Superose-6 size exclusion column in 20 mM Tris-HCl pH 8.0, 450 mM KCl, 10 mM CaCl~2~, 10 mM MgCl~2~, 0.1 μg/ml pepstatin A, 1 μg/ml aprotinin, 0.005% digitonin and 0.05 mg/ml POPE:POPC:POPA 5:5:1 (w:w:w). All purification procedures were carried out either on ice or at 4°C. The peak fractions corresponding to the tetrameric Slo1 channel was concentrated to about 7 mg/ml and used for preparation of cryo-EM sample grids.

The Ca^2+^-free hsSlo1 protein sample was prepared in a similar fashion with 5 mM EGTA and 15 mM MgCl~2~ substituting 10 mM CaCl~2~ and 10 mM MgCl~2~. For the Ca^2+^-bound and Ca^2+^-free hsSlo1-β4 complex protein samples, 1% Digitonin was used for extraction and final protein concentration was at \~8.5 mg/ml.

For confirmative studies of the two predicted N-glycosylation sites on human β4, single and double N2Q mutants were made and confirmed by sequencing (Genewiz). The hsSlo1~EM~-β4 glycosylation mutants complex were expressed and purified the same as hsSlo1~EM~-β4 wild-type. The purified proteins were analyzed with tandem mass spectrometry (ms/ms) at the Proteomics Resource Center of the Rockefeller University.

Cryo-EM grid preparation and imaging {#s4-2}
------------------------------------

3.5 μl of purified protein sample was pipetted onto glow-discharged Quantifoil Au 400 mesh, R 1.2/1.3 holey carbon grids (Quantifoil). Grids were blotted for 4 s with a blotting force of 1 and humidity of 100% and flash frozen in liquid-nitrogen-cooled liquid ethane using a FEI Vitrobot Mark IV (FEI). Grids were then transferred to a FEI Titan Krios electron microscope operating at an acceleration voltage of 300 keV. Images were recorded in an automated fashion on a Gatan K2 Summit detector (Gatan) set to super-resolution mode using SerialEM ([@bib55]). Images of Ca^2+^-bound (open) hsSlo1-β4 complex were recorded with an energy filter of 20 eV at a super-resolution pixel size of 0.52 Å and defocus range of 0.7 to 2.0 μm, for 10 s with a subframe exposure time of 200 ms in a dose of approximately eight electrons per pixel per second (a total accumulated dose of approximately 74 electrons per Å^2^ over 50 subframes or approximately 1.5 electrons per Å^2^ per subframe). Images of Ca^2+^-free (closed) hsSlo1-β4 complex were recorded at a super-resolution pixel size of 0.65 Å and defocus range of 0.7 to 2.0 μm, for 15 s with a subframe exposure time of 300 ms in a dose of approximately 10 electrons per pixel per second (a total accumulated dose of approximately 89 electrons per Å^2^ over 50 subframes or approximately 1.78 electrons per Å^2^ per subframe). Images of Ca^2+^-bound (open) hsSlo1 and Ca^2+^-free (closed) hsSlo1 were recorded at a super-resolution pixel size of 0.65 Å and defocus range of 0.8 to 2.4 μm for 15 s with a subframe exposure time of 300 ms in a dose of approximately 10 electrons per pixel per second (a total accumulated dose of approximately 89 electrons per Å^2^ over 50 subframes or approximately 1.78 electrons per Å^2^ per subframe).

Image processing and map calculation {#s4-3}
------------------------------------

Dose-fractionated super-resolution images were 2×2 down sampled by Fourier cropping for motion correction with Unblur or MotionCorr2 (5×5 patches) ([@bib31]; [@bib96]). The parameters of the contrast transfer function were estimated by ctffind4 or GCTF ([@bib69]; [@bib94]). Following motion correction, \~5 k particles from a subset of the images were interactively selected using RELION to generate templates representing different views for automated particle selection with RELION autopicking ([@bib71]) or gautomatch (<https://www.mrc-lmb.cam.ac.uk/kzhang/>). The autopicked particles were manually inspected to remove false positives. The resulting particle images were then subjected to 2D classification in RELION to remove particles belonging to low-abundance classes and to generate projection averages for initial model generation with EMAN2 imposing C4 symmetry ([@bib77]) or cryoSPARC ([@bib67]).

For the Ca^2+^-bound (open) conformation of hsSlo1-β4 complex, \~483 k particle images were selected from 5410 micrographs following 2D classification in RELION ([@bib71]). Orientation and translational parameters for the \~483 k particle images were then refined with the auto-refine algorithm of RELION, using the EMAN2-generated initial model as a reference. The refined particle images were subjected to RELION's 3D classification algorithm without a mask, skipping image alignment. Orientation and translational parameters for the 133 k particle images in the best class were refined using the auto-refine algorithm of RELION, resulting in a map with a resolution of 3.8 Å before postprocessing. The refined particle images were subjected to another round of 3D classification without image alignment, resulting in one major class. Orientation and translational parameters for the 118 k particle images in this class were refined using the auto-refine algorithm of RELION. The rotational and translational parameters determined by RELION were used as the input for further refinement by FrealignX, during which the resolution of the reference map used for alignment was limited to 6 Å to minimize over-refinement, resulting in a final map that achieved a resolution of 3.2 Å as assessed by Fourier shell correlation using the 0.143 cut-off criterion ([Figure 1---figure supplements 2](#fig1s2){ref-type="fig"}--[3](#fig1s3){ref-type="fig"} and [Table 1](#table1){ref-type="table"}) ([@bib50]; [@bib30]). The final map was sharpened using an isotropic b-factor of −100 Å^2^ prior to model building and coordinate refinement. To improve the map of the extracellular domain of β4, focused 3D classification around the β4 subunit was performed on the two best classes from the first round of 3D classification. The 62 k particles from the best class were further refined using FrealignX masking around β4, resulting in a final map that achieved a resolution of 3.9 Å as assessed by Fourier shell correlation using the 0.143 cut-off criterion. This focus-refined map was used for initial de novo building of the β4 EC domain.

For the Ca^2+^-free (closed) conformation of hsSlo1-β4 complex, \~269 k particle images were selected from 3405 micrographs following 2D classification in cryoSPARC ([@bib67]). Ab initio reconstruction of the 269 k particles (requesting three classes) resulted in two good classes with 198 k particles. Orientation and translational parameters for these particles were refined with the auto-refine algorithm of RELION ([@bib71]). The refined particle images were subjected to RELION's 3D classification algorithm without image alignment. One best class (\~43 k particles) out of the requested six classes was refined using the auto-refine algorithm of RELION, resulting in a map that achieved a resolution of 4.2 Å before postprocessing. The rotational and translational parameters determined by RELION were used as the input for further refinement by FrealignX, during which the resolution of the reference map used for alignment was limited to 6 Å to minimize over-refinement, resulting in a final map that achieved a resolution of 3.5 Å as assessed by Fourier shell correlation using the 0.143 cut-off criterion ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"} and [Table 1](#table1){ref-type="table"}) ([@bib50]; [@bib30]). The map was sharpened using an isotropic b-factor of −100 Å^2^ prior to model building and coordinate refinement.

For the Ca^2+^-bound (open) conformation of hsSlo1, \~93 k particle images were selected from 1215 micrographs following 2D classification in RELION ([@bib71]). Orientation and translational parameters for these particle images were then refined with the auto-refine algorithm of RELION, using the EMAN2-generated initial model as a reference. The refined particle images were subjected to RELION's 3D classification algorithm without image alignment. One best class out of the requested four classes, accounting for \~30% of the total input, was refined using the auto-refine algorithm of RELION, resulting in a map that achieved a resolution of 4.5 Å before postprocessing. The rotational and translational parameters determined by RELION were used as the input for 40 additional cycles of refinement by FREALIGN, during which the resolution of the reference map used for alignment was limited to 6 Å to minimize over-refinement, resulting in a final map that achieved a resolution of 3.8 Å as assessed by Fourier shell correlation using the 0.143 cut-off criterion ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"} and [Table 1](#table1){ref-type="table"}) ([@bib50]; [@bib30]). The map was sharpened using an isotropic b-factor of −100 Å^2^ prior to model building and coordinate refinement.

For the Ca^2+^-free (closed) conformation of hsSlo1, orientation and translational parameters of \~437 k autopicked particle images from 1292 micrographs were refined with the auto-refine algorithm of RELION using an initial model generated from cryoSPARC ([@bib71]; [@bib67]). The refined particle images were subjected to RELION's 3D classification algorithm without image alignment, requesting six classes. Orientation and translational parameters for the 54 k particle images in the best class was refined using the auto-refine algorithm of RELION, resulting in a map that achieved a resolution of 4.9 Å before postprocessing. The rotational and translational parameters determined by RELION were used as the input for 40 additional cycles of refinement by FREALIGN, during which the resolution of the reference map used for alignment was limited to 7 Å to minimize over-refinement, resulting in a final map that achieved a resolution of 4.0 Å as assessed by Fourier shell correlation using the 0.143 cut-off criterion ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"} and [Table 1](#table1){ref-type="table"}) ([@bib50]; [@bib30]). The map was sharpened using an isotropic b-factor of −200 Å^2^ prior to model building and coordinate refinement.

Model building and refinement {#s4-4}
-----------------------------

The transmembrane domain from the cryo-EM structure of open aplysia Slo1 (PDB 5TJ6) and the X-ray crystal structure of the human Slo1 gating-ring (PDB 3MT5) were docked into the cryo-EM density map of the Ca^2+^-bound Slo1-β4 complex using UCSF Chimera and then manually rebuilt in Coot to fit the density ([@bib65]; [@bib25]). For the β4 subunit, the cryo-EM density map from a focus-classified and refined class was used for initial de novo building. The two transmembrane helices TM1 and TM2 were built by first placing secondary structure elements into the density. Once the backbone was traced, the sequence was registered by the assignment of large sidechains. The extracellular domain of β4 was built by identifying large sidechains, four pairs of disulfide bonds as well as the two N-glycosylation sites. An essentially complete model of β4 subunit was built with the exception of the very N-terminal six residues (aa 1--6) and C-terminal five residues (aa 206--210) for which no density was visible. The Slo1-β4 model after manual rebuilding in Coot was subjected to real-space refinement in Phenix ([@bib2]). The final model after a few iterations of real-space refinement and manual rebuilding has good geometry and contains amino acids 16--54, 91--569, 577--615, 681--833, and 871--1056 of the α subunit, and amino acids 7--205 of the β4 subunit ([Table 1](#table1){ref-type="table"}).

The atomic model of the Ca^2+^-bound (open) Slo1-β4 complex was used as a starting model for the other three states followed by multiple rounds of manual rebuilding in Coot and real-space refinement with Phenix ([@bib25]; [@bib2]). The final models all have good geometry ([Table 1](#table1){ref-type="table"}). Figures were prepared using PyMOL (Molecular Graphics System, Version 2.2.0 Schrodinger, LLC) and Chimera ([@bib65]).

Mutagenesis {#s4-5}
-----------

HsSlo1~EM~, wild-type human β4 and β1 subunits were subcloned into a pGEM vector. Guided by the structure, in particular the relative location of the bound lipid molecules, we divided the entire β4 sequence into 10 regions: 1) the unresolved N-terminus ('N-tail', aa 1--6); 2) the short loop preceding TM1 ('N-loop', aa 7--12); 3) TM1 near the inner membrane leaflet headgroup layer ('TM1 ILH', aa 13--19); 4) TM1 near the inner membrane leaflet acyl chain layer ('TM1 ILA', aa 20--29); 5) TM1 near the outer membrane leaflet layer ('TM1 OL', aa 30--48); 6) EC domain (aa 49--163); 7) TM2 near the outer membrane leaflet layer ('TM2 OL', aa 164--180); 8) TM2 near the inner membrane leaflet acyl chain layer ('TM2 ILA', aa 181--190); 9) TM2 near the inner membrane leaflet headgroup layer ('TM2 ILH', aa 191--205); and 10) unresolved C-terminus ('C-tail', aa 206--210) ([Figure 4B](#fig4){ref-type="fig"}). Mutants were made by replacing one or more of these 10 regions of β4 mostly with the equivalent residues from the β1 subunit based on the sequence alignment ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"} and [Table 2](#table2){ref-type="table"}). All the mutants were generated using PCR and incorporation of the mutation(s) was verified by sequencing (GeneWiz).

Excised Inside-out patch recordings {#s4-6}
-----------------------------------

The constructs used for cryo-EM sample preparation: hsSlo1~EM~, wild-type human β4 and β1 in pEG BacMam vector, were used for measuring the Ca^2+^ sensitivity of the channel in HEK293T cells (ATCC) in voltage-clamp inside-out patch configuration.

0.5 μg of hsSlo1~EM~ alone or 0.5 μg of hsSlo1~EM~ together with 0.5 μg of human β4 or β1 were transfected into HEK293T cells at about 50--60% confluency using FuGENE HD transfection reagent following manufacturer's instructions (Promega). Cells were transferred to 30°C after transfection and recordings were carried out 18--24 hr post-transfection.

Pipettes of borosilicate glass (Sutter Instruments; BF150-86-10) were pulled to \~2--3 MΩ resistance with a micropipette puller (Sutter Instruments; P-97) and polished with a microforge (Narishige; MF-83). All recordings were performed at room temperature in voltage-clamp excised inside-out patch configuration with an Axopatch 200B amplifier (Molecular Devices), Digidata 1440A analogue-to-digital converter interfaced with a computer, and pClamp10.5 software (Axon Instruments, Inc) for controlling membrane voltage and data acquisition. The recorded signal was filtered at 1 kHz and sampled at 10 kHz.

The bath solution contained 20 mM HEPES-NaOH, 136 mM KGluconate, 4 mM KCl and 10 mM Glucose, pH 7.4 (adjusted with NaOH) with an osmolarity of \~300 Osm/L. The bath solution supplemented with 2 mM MgCl~2~ was used as the pipette solution. Solutions used for the Ca^2+^-titration experiments contained the bath solution supplemented with an increasing amount of CaCl~2~: 0.5 μM, 2.5 μM, 10 μM, 50 μM. Note here the Ca^2+^ concentrations refer to the amount of Ca^2+^ added from a stock of CaCl~2~, not the free \[Ca^2+^\]. Ca^2+^-titration was achieved with local perfusion using a fast-pressurized microperfusion system (ALA Scientific; ALAVC3 × 8 PP). At each Ca^2+^ concentration, the ionic current was measured with a voltage-family protocol.

Two-electrode voltage clamp (TEVC) recordings {#s4-7}
---------------------------------------------

HsSlo1~EM~, wild-type human β1, wild-type human β4 and β4 mutants in a pGEM vector were used for expression in Xenopus oocytes. cRNAs were prepared from NdeI linearized plasmids using AmpliCap-Max T7 high yield message maker kit (CELLSCRIPT) and purified with mMESSAGE mMACHINE kit (ThermoFisher Scientific). cRNA concentration was estimated based on agarose gel.

Xenopus oocytes were harvested from mature female *Xenopus laevis* and defolliculated by collagenase treatment for 1--2 hr at room temperature. Oocytes were then rinsed thoroughly and stored in ND96 solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl~2~, 1.0 mM MgCl~2~, 5 mM HEPES, 50 µg/ml gentamycin, pH 7.6 with NaOH). Defolliculated oocytes were selected 2--4 hr after collagenase treatment and injected with cRNA the next day. For co-expression of hsSlo1 and β, cRNAs at a ratio of 1: 2 (w:w) were injected. The injected oocytes were incubated in ND96 solution before recording. Recordings were usually carried out 1--2 days post-injection for ionic current measurements. All oocytes were stored in an incubator at 18°C.

All recordings were performed at room temperature in two-electrode voltage-clamp configuration with an oocyte clamp amplifier (OC-725C, Warner Instrument Corp.), Digidata 1550B analogue-to-digital converter interfaced with a computer, and pClamp11.0.1 software (Axon Instruments, Inc) for controlling membrane voltage and data acquisition. The recorded signal was filtered at 1 kHz and sampled at 10 kHz.

Oocytes were recorded with bath solution of either low Ca^2+^ ND96 recording solution (96 mM NaCl, 2 mM KCl, 0.3 mM CaCl~2~, 1.0 mM MgCl~2~, 5 mM HEPES, pH 7.6 with NaOH) or high K recording solution (98 mM KCl, 0.3 mM CaCl~2~, 1.0 mM MgCl~2~, 5 mM HEPES, pH 7.6 with NaOH). To investigate voltage-dependent channel activation and deactivation, oocytes were held at either −80 mV for recordings in low Ca^2+^ ND96 solution or 0 mV for recordings in high K solution, with pulse potential starting from the holding potential and ending between +120 mV and +140 mV in 10 mV increments. The repolarization potential was +40 mV.

Data analysis {#s4-8}
-------------

For voltage-dependent channel activation recordings at a series of Ca^2+^ concentrations in excised inside-out patch experiments, the amount of current at the repolarization step (i.e. tail current), typically measured 4--5 ms after the depolarization step when most of the capacitive current had decayed, was normalized against the maximal current (I/I~max~) at that concentration and plotted as a function of the depolarization voltage (I-V plot). This voltage-dependent activation plot was fitted with the two-state Boltzmann function:$$\frac{I}{I_{max}} = \frac{1}{1 + e^{- {({\frac{ZF}{RT}{({V - V_{m}})}})}}}$$where I/I~max~ is the fraction of the maximal current, V is the depolarization voltage to open the channels, V~m~ is the voltage at which the channels have reached 50% of their maximal current, F is the Faraday constant, R is the gas constant, T is the absolute temperature, and Z is the apparent valence of voltage dependence.

For the voltage-dependent channel activation recordings made in oocytes with TEVC, the channel activation time course at the depolarization step (100 mV) and the deactivation time course at the repolarization step (40 mV) (typically spanning from 4 to 5 ms after the depolarization step or repolarization step when most of the capacitive current had decayed until the current has reached its steady state) were quantified by fitting with a single exponential function:$$I\left( t \right) = A\left( {1 - e^{\frac{- t}{\tau}}} \right) + C$$

All data analysis and fits were carried out with the Clampfit software (Axon Instruments, Inc).
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The B-factor sharpened 3D cryo-EM density maps and atomic coordinates of the Ca2+-bound (open) hsSlo1-beta4 complex (accession number EMD-21025 and 6V22), the Ca2+-free (closed) hsSlo1-beta4 complex (accession number EMD-21028 and 6V35), the Ca2+-bound (open) hsSlo1 (accession number EMD-21029 and 6V38), and the Ca2+-free (closed) hsSlo1 (accession number EMD-21036 and 6V3G) have been deposited in the Worldwide Protein Data Bank (wwPDB).

The following datasets were generated:

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-bound (open) hsSlo1-beta4 complexProtein Data BankPDB 6V22

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-free (closed) hsSlo1-beta4 complexProtein Data BankPDB 6V35

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-bound (open) hsSlo1Protein Data BankPDB 6V38

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-free (closed) hsSlo1Protein Data BankPDB 6V3G

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-bound (open) hsSlo1-beta4 complexEMDataBankEMD-21025

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-free (closed) hsSlo1-beta4 complexEMDataBankEMD-21028

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-bound (open) hsSlo1EMDataBankEMD-21029

TaoXMacKinnonR2019Single particle cryo-EM structure of Ca2+-free (closed) hsSlo1EMDataBankEMD-21036
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**Acceptance summary:**

Slo or BK calcium and voltage activated potassium channels serve a wide variety of roles in diverse tissues where their properties are modified in tissue-specific ways by alternative splicing, association of different accessory (β and γ) subunits and protein modification. Tao and MacKinnon present a CryoEM derived structure of the human Slo chanel containing the brain associated β4 subunit, an auxiliary subunit that alters channel gating characteristics. They present atomic models of four different states of the channel, in the presence and absence of Ca^2+^ and presence and absence of the β4 subunit. Their study confirms that the human channel structure does not substantially differ from the previously solved *Aplysia* channel and maintains its general structure when bound to the β4 subunit.

**Decision letter after peer review:**

\[Editors' note: minor issues and corrections have not been included, so there is not an accompanying Author response.\]

Thank you for submitting your article \"Molecular structures of the human Slo1 K + channel in complex with b4\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Kenton Swartz as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Niko Grigorieff (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The paper describes the first structures of Slo1 (BK) potassium channels in complex with a regulatory β subunit and as such makes significant and important contribution to the understanding of these important ion channels.

Essential revisions:

The reviewers find the work to be of high quality, but they bring up several fairly minor issues that need to be addressed. These are clearly described in the individual reviews enclosed below, and should be easily addressed.

Reviewer \#1:

This is a relatively straightforward structural paper providing the first structural information regarding a BK regulatory subunit in association with full-length BK channels. The paper includes new structures for both relatively full-length human Slo1 in both putative open and closed conformations, with and without the β4subunit. The structural work is complemented by functional evaluation of which part of β4 may impact on channel function, taking advantage of the chimeras designed around segments based on the β structures. Although not major insights are gained from the functional work, it does highlight a few loci that may motivate future investigation.

Reviewer \#2:

Tao and MacKinnon have determined high-resolution cryo-EM structures of human Slo1 ion channel, a channel that is gated by voltage and Ca^2+^. They show atomic models of four different states of the channel, corresponding to combinations of presence and absence of Ca^2+^ and presence and absence of the β4 subunit, an auxiliary subunit that alters channel gating characteristics. The structures of human Slo1 are very similar to homologous *Aplysia* Slo1, which the authors have studied previously, displaying almost identical Ca^2+^ dependent conformational changes. However, the structure of any of the tissue-specific β subunits was hitherto unknown, and the structure shown in the present manuscript represents one of the main results. The authors provide detailed descriptions of the interactions between β4 and the channel, forming an octameric complex with 1:1 stoichiometry.

Since the structures of the channel in the presence and absence of β4 are virtually identical, it is not obvious how β4 affects channel gating. β4 has two transmembrane segments, and based on the new cryo-EM structures, the authors suggest that binding to the channel may alter its interaction with lipid molecules in the native membrane environment, potentially affecting gating behavior. Furthermore, contacts between β4 and the channel may shift its equilibrium between open and closed states, which would not alter the conformations of the fully open and fully closed states observed under the conditions used for the cryo-EM experiments. The β4-bound structures also explain how the auxiliary subunit interferes with toxin binding, which was previously observed for Slo1.

The cryo-EM work follows standard procedures and is of high quality, permitting reliable building and refinement of atomic models. The main weakness of this manuscript is the lack of a clear molecular mechanism of how β4 alters the characteristics of the Slo1 channel. The authors perform mutagenesis of β4, as well as electrophysiology, highlighting the β4 N-terminal tail as the segment that conveys the biggest change. Unfortunately, this part of β4 is disordered and not visible in any of the reconstructions, not clarifying the mechanism. The structures also do not offer any insight into how β4 affects the voltage sensor. The main advance of this study is therefore the structure of β4, in complex with the Slo1 α subunit. As explained by the authors, this will serve as a basis for further studies to design experiments and test hypotheses on the molecular mechanism of β subunits binding to Slo channels. Given that there was no structure of a β subunit known, and that the present structures show that some previous conclusions based on more indirect experiments were wrong, this work is of sufficiently broad interest and significance for publication in *eLife*.

Reviewer \#3:

The paper by Tao and MacKinnon provides us, for the first time, with the structure of the BK channel formed by the αβ4 complex. The structure of the BK channel, obtained at a resolution of 3.2 Å, shows a BK channel in which four β4 subunits are intercalated in between two α-subunit voltage sensors. The β4 does not introduce large conformational changes when BK structures with and without the β4 subunit or with and without Ca^2+^ are compared. The authors hypothesize that \"β4 has the role of modulating the relative stability of pre-existing conformations\". The paper provides a wealth of information about the detailed structure of the β4 in the αβ4 complex and the molecular interactions between the α and the β4 subunit. In this regard, it is important to mention that TM2 forms an interface with lipid molecules and that on the extracellular side, β4 forms a well-defined tetrameric domain, defining a crown-like structure. The later structure gives a natural explanation to the observation that the rates of association and dissociation of scorpion toxins are highly modified in αβ4 BK channels. The β4 structure and electrophysiological and mutagenesis experiments also indicate that the interaction between the N-terminus of TM1 of β4 and some domains of the gating ring is involved in the modulation of channel gating.

This is an important paper that provides us with a structure that without a doubt, will allow a further understanding of how β subunits modulate BK channel gating.
